Whit Mayo
Stock Analyst at Wells Fargo
(4.10)
# 591
Out of 4,747 analysts
201
Total ratings
56.2%
Success rate
10.94%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BK BNY Mellon | Maintains: Equal-Weight | $82 → $86 | $86.34 | -0.39% | 6 | Jan 16, 2025 | |
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $8.57 | -6.65% | 2 | Nov 19, 2024 | |
| RF Regions Financial | Maintains: Equal-Weight | $24 → $28 | $24.75 | +13.13% | 5 | Nov 15, 2024 | |
| PNC PNC Financial | Maintains: Overweight | $215 → $235 | $201.72 | +16.50% | 5 | Nov 15, 2024 | |
| FITB Fifth Third Bancorp | Maintains: Overweight | $52 → $54 | $44.78 | +20.59% | 4 | Nov 15, 2024 | |
| BAC Bank of America | Maintains: Overweight | $52 → $56 | $46.84 | +19.56% | 4 | Nov 15, 2024 | |
| MS Morgan Stanley | Upgrades: Equal-Weight | $107 → $142 | $138.54 | +2.50% | 5 | Nov 15, 2024 | |
| ARDT Ardent Health Partners | Maintains: Outperform | $23 → $25 | $14.80 | +68.92% | 2 | Nov 12, 2024 | |
| AHCO AdaptHealth | Maintains: Buy | $13 → $12 | $10.68 | +12.36% | 10 | Nov 6, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $303.11 | -17.52% | 12 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $96.78 | +3.33% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $5 | $4.76 | +5.04% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $22.73 | -34.01% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $45 → $52 | $63.53 | -18.15% | 2 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $55 | $79.94 | -31.20% | 3 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $542.48 | +3.23% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $188.71 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $50 → $38 | $57.77 | -34.22% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $390 | $637.80 | -38.85% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $100.40 | -3.39% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $155 | $199.82 | -22.43% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $20 | $17.65 | +13.31% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $302.82 | +10.63% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $580 | $405.40 | +43.07% | 3 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $96 → $85 | $92.48 | -8.09% | 16 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $328.70 | -12.99% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $25.75 | +55.34% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $22.73 | +71.58% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $4.59 | -67.32% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $3.51 | +754.70% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $16 | $14.46 | +10.65% | 10 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $139.67 | -60.62% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $103 | $43.54 | +136.56% | 10 | Aug 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $94.93 | +84.35% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $15.22 | +24.84% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.29 | +21.58% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $248.51 | -18.31% | 2 | May 1, 2018 |
BNY Mellon
Jan 16, 2025
Maintains: Equal-Weight
Price Target: $82 → $86
Current: $86.34
Upside: -0.39%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $8.57
Upside: -6.65%
Regions Financial
Nov 15, 2024
Maintains: Equal-Weight
Price Target: $24 → $28
Current: $24.75
Upside: +13.13%
PNC Financial
Nov 15, 2024
Maintains: Overweight
Price Target: $215 → $235
Current: $201.72
Upside: +16.50%
Fifth Third Bancorp
Nov 15, 2024
Maintains: Overweight
Price Target: $52 → $54
Current: $44.78
Upside: +20.59%
Bank of America
Nov 15, 2024
Maintains: Overweight
Price Target: $52 → $56
Current: $46.84
Upside: +19.56%
Morgan Stanley
Nov 15, 2024
Upgrades: Equal-Weight
Price Target: $107 → $142
Current: $138.54
Upside: +2.50%
Ardent Health Partners
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $14.80
Upside: +68.92%
AdaptHealth
Nov 6, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $10.68
Upside: +12.36%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $303.11
Upside: -17.52%
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $96.78
Upside: +3.33%
May 14, 2024
Downgrades: Market Perform
Price Target: $5
Current: $4.76
Upside: +5.04%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $22.73
Upside: -34.01%
Dec 14, 2023
Maintains: Underweight
Price Target: $45 → $52
Current: $63.53
Upside: -18.15%
Aug 23, 2023
Maintains: Overweight
Price Target: $60 → $55
Current: $79.94
Upside: -31.20%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $542.48
Upside: +3.23%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $188.71
Upside: -
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $50 → $38
Current: $57.77
Upside: -34.22%
Apr 3, 2023
Maintains: Overweight
Price Target: $420 → $390
Current: $637.80
Upside: -38.85%
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $100.40
Upside: -3.39%
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $165 → $155
Current: $199.82
Upside: -22.43%
Apr 3, 2023
Maintains: Overweight
Price Target: $21 → $20
Current: $17.65
Upside: +13.31%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $302.82
Upside: +10.63%
Jan 26, 2023
Reiterates: Outperform
Price Target: $580
Current: $405.40
Upside: +43.07%
Jan 5, 2023
Maintains: Market Perform
Price Target: $96 → $85
Current: $92.48
Upside: -8.09%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $328.70
Upside: -12.99%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $25.75
Upside: +55.34%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $22.73
Upside: +71.58%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $4.59
Upside: -67.32%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $3.51
Upside: +754.70%
Nov 4, 2022
Maintains: Market Perform
Price Target: $20 → $16
Current: $14.46
Upside: +10.65%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $139.67
Upside: -60.62%
Aug 26, 2022
Maintains: Outperform
Price Target: $95 → $103
Current: $43.54
Upside: +136.56%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $94.93
Upside: +84.35%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $15.22
Upside: +24.84%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.29
Upside: +21.58%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $248.51
Upside: -18.31%